Targeting CCR4 as an emerging strategy for cancer therapy and vaccines

被引：36
|
作者：
Bayry, Jagadeesh [1 ,2 ,3 ]
Tartour, Eric [4 ,5 ]
Tough, David F. [6 ]
机构：
[1] Inst Nacl Sante Rech Med, Unite 1138, F-75006 Paris, France
[2] Univ Paris 06, Ctr Rech Cordeliers, F-75006 Paris 6, France
[3] Univ Paris 05, UMR S 1138 Paris, F-75006 Paris, France
[4] Univ Paris 05, PARCC, Unite 970, Inst Natl Sante Rech Med, F-75015 Paris, France
[5] Hop Europeen Georges Pompidou, Serv Immunol Biol, AP HP, F-75015 Paris, France
[6] GlaxoSmithKline Med Discovery Ctr, Innmunoinflammat Therapeut Area, Epinova Discovery Performance Unit, Stevenage SG1 2NY, Herts, England
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2014年 / 35卷 / 04期
关键词：
REGULATORY T-CELLS; SURVIVAL; LYMPHOMA; ANTIBODY;
D O I：
10.1016/j.tips.2014.02.003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：163 / 165
页数：3
相关论文
共 50 条
  • [21] Synthesis of thiourea derivatives as CCR4 antagonists
    Fang Zhao~(a
    ChineseChemicalLetters, 2009, 20 (03) : 296 - 299
  • [22] Identification of chemokine receptor CCR4 antagonist
    Purandare, AV
    Gao, AM
    Wan, HH
    Somerville, J
    Burke, C
    Seachord, C
    Vaccaro, W
    Wityak, J
    Poss, MA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (10) : 2669 - 2672
  • [23] Synthesis of thiourea derivatives as CCR4 antagonists
    Zhao, Fang
    Xiao, Jun Hai
    Wang, Ying
    Li, Song
    CHINESE CHEMICAL LETTERS, 2009, 20 (03) : 296 - 299
  • [24] CCR4 is a determinant of melanoma brain metastasis
    Klein, Anat
    Sagi-Assif, Orit
    Meshel, Tsipi
    Telerman, Alona
    Izraely, Sivan
    Ben-Menachem, Shlomit
    Bayry, Jagadeesh
    Marzese, Diego M.
    Ohe, Shuichi
    Hoon, Dave S. B.
    Erez, Neta
    Witz, Isaac P.
    ONCOTARGET, 2017, 8 (19) : 31079 - 31091
  • [25] The importance of CCR4 and CCR6 in experimental autoimmune encephalomyelitis
    Moriguchi, Kota
    Miyamoto, Katsuichi
    Tanaka, Noriko
    Yoshie, Osamu
    Kusunoki, Susumu
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 257 (1-2) : 53 - 58
  • [26] A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
    Berlato, Chiara
    Khan, Moddasar N.
    Schioppa, Tiziana
    Thompson, Richard
    Maniati, Eleni
    Montfort, Anne
    Jangani, Maryam
    Canosa, Monica
    Kulbe, Hagen
    Hagemann, Urs B.
    Duncan, Alexander R.
    Fletcher, Laura
    Wilkinson, Robert W.
    Powles, Thomas
    Quezada, Sergio A.
    Balkwill, Frances R.
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (03): : 801 - 813
  • [27] Genetic Polymorphisms of CCL22 and CCR4 in Patients with Lung Cancer
    Erfani, Nasrollah
    Ahmadi, Ahmadi-Sina Nedaei
    Ghayumi, Mohammad Ali
    Mojtahedi, Zahra
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2014, 39 (04) : 367 - 373
  • [28] Functioning CCR4 is expressed and associated with poor prognosis in gastric cancer patients
    Bae, Jae-Moon
    Lee, Jun Ho
    Lee, Ji Young
    Kook, Myoung Cheorl
    CANCER RESEARCH, 2008, 68 (09)
  • [29] The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
    Li, Ji-Yu
    Ou, Zhou-Luo
    Yu, San-Jian
    Gu, Xiao-Li
    Yang, Chen
    Chen, Ao-Xiang
    Di, Gen-Hong
    Shen, Zhen-Zhou
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 837 - 848
  • [30] Recurrent angiolymphoid hyperplasia with eosinophilia with CCR4 expression
    Nakajima, Kaori
    Kuroda, Eri
    Takeuchi, Sora
    Kadono, Takafumi
    Miyagaki, Tomomitsu
    DERMATOLOGICA SINICA, 2021, 39 (02) : 99 - 100
12345